GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PMD Device Solutions AB (OSTO:PMDS) » Definitions » EV-to-EBIT

PMD Device Solutions AB (OSTO:PMDS) EV-to-EBIT : -13.41 (As of Jun. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is PMD Device Solutions AB EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PMD Device Solutions AB's Enterprise Value is kr139.74 Mil. PMD Device Solutions AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-10.42 Mil. Therefore, PMD Device Solutions AB's EV-to-EBIT for today is -13.41.

The historical rank and industry rank for PMD Device Solutions AB's EV-to-EBIT or its related term are showing as below:

OSTO:PMDS' s EV-to-EBIT Range Over the Past 10 Years
Min: -166.88   Med: -3.21   Max: -0.01
Current: -13.41

During the past 8 years, the highest EV-to-EBIT of PMD Device Solutions AB was -0.01. The lowest was -166.88. And the median was -3.21.

OSTO:PMDS's EV-to-EBIT is ranked worse than
100% of 451 companies
in the Medical Devices & Instruments industry
Industry Median: 19.6 vs OSTO:PMDS: -13.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. PMD Device Solutions AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr227.31 Mil. PMD Device Solutions AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-10.42 Mil. PMD Device Solutions AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -4.58%.


PMD Device Solutions AB EV-to-EBIT Historical Data

The historical data trend for PMD Device Solutions AB's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PMD Device Solutions AB EV-to-EBIT Chart

PMD Device Solutions AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -2.58 -2.47 -1.91 -1.19 -

PMD Device Solutions AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.47 -0.23 -0.17 - -21.82

Competitive Comparison of PMD Device Solutions AB's EV-to-EBIT

For the Medical Devices subindustry, PMD Device Solutions AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PMD Device Solutions AB's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PMD Device Solutions AB's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PMD Device Solutions AB's EV-to-EBIT falls into.



PMD Device Solutions AB EV-to-EBIT Calculation

PMD Device Solutions AB's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=139.744/-10.419
=-13.41

PMD Device Solutions AB's current Enterprise Value is kr139.74 Mil.
PMD Device Solutions AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PMD Device Solutions AB  (OSTO:PMDS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

PMD Device Solutions AB's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-10.419/227.3076
=-4.58 %

PMD Device Solutions AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr227.31 Mil.
PMD Device Solutions AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-10.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PMD Device Solutions AB EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of PMD Device Solutions AB's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PMD Device Solutions AB (OSTO:PMDS) Business Description

Traded in Other Exchanges
Address
Fogdevreten 2, Solna, SWE, SE-171 65
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.

PMD Device Solutions AB (OSTO:PMDS) Headlines

No Headlines